Intellectual Property
-
March 27, 2025
Coping with the implied undertaking rule
Recent decisions in the Federal Court deal with the scope of the implied undertaking rule.
-
March 25, 2025
Borden Ladner Gervais adds new partner
Borden Ladner Gervais LLP (BLG) has welcomed Noelle Engle-Hardy to the firm as partner in its intellectual property group.
-
March 24, 2025
Maple-washing: Regulatory and civil liability risks of calling a product Canadian
Canadian consumers are increasingly eager to support domestic products and are therefore scrutinizing product labels more than ever before. Meanwhile, Canadian businesses are working to meet the growing demand for Canadian-made products. While origin claims about products are generally voluntary, there can be significant legal risks from both regulators and civil claimants if those claims are false or misleading.
-
March 20, 2025
Strict government regulations on AI could diminish benefits, warns report
The adoption of artificial intelligence (AI) will raise living standards and is likely to contribute to net job creation, but those benefits could be reduced by over-regulation, predicts a new report by the conservative public policy think-tank the Fraser Institute,
-
March 20, 2025
New trademark agent joins Smart & Biggar
Smart & Biggar has welcomed Jessica Rustige to its Ottawa office.
-
March 19, 2025
Ford announces new Ontario cabinet, most ministers remain in position
Ontario Premier Doug Ford has announced his new cabinet, emphasizing that they will deliver on the province’s mandate to “do whatever is necessary to protect Ontario in the face of tariffs from the United States.”
-
March 19, 2025
Trade investigations announced targeting resin product from China and Pakistan
The Canadian Border Services Agency (CBSA) is initiating investigations to determine if polyethylene terephthalate (PET) resin originating in or exported from China and Pakistan is being sold at unfair prices in Canada and whether PET resin originating in or exported from China is being subsidized.
-
March 13, 2025
Ontario Court of Appeal: Apotex not entitled to damages for generic drug's delayed market entry
The Ontario Court of Appeal has ruled that generic drugmaker Apotex is not entitled to damages for the delayed entry of a generic drug that was based on a patent held by Eli Lilly, despite the fact that the patent was invalidated in a separate action by Teva.
-
March 12, 2025
B.C. Court of Appeal upholds class action certification against Qualcomm, strikes conspiracy claims
The B.C. Court of Appeal has upheld the certification of price maintenance, unlawful means and unjust enrichment claims against California-based Qualcomm Inc. over its allegedly anti-competitive patent licensing and modem sales practices in a consumer class action.
-
March 06, 2025
Embattled Ontario law society CEO ‘no longer employed’ with regulator amid pay hike fallout
Law Society of Ontario (LSO) CEO Diana Miles is “no longer employed” with the regulator after a controversy regarding her salary came to light.